An analog of the natural hormone amylin.

Through our global co-development and commercialization contract with Takeda, we are committed to developing innovative therapies to help the thousands of people who want better answers to manage obesity. Today’s announcement can be an important step forward in assisting us make good on that commitment. We are pleased with the results of the Phase 2 extension research for the pramlintide/metreleptin mixture therapy, said Nancy Joseph-Ridge, M.D., general manager of Takeda’s Pharmaceutical Advancement Division. This potential fresh therapy continues to build on our dedication to the management of obesity.Jude Children’s Analysis Hospital’s annual campaign CVS/pharmacy begins its annual in store fundraiser for the sixth year to support the St. Jude Children’s Research Hospital Thanks and Giving campaign, beginning this Sunday and running right through December 12. CVS/pharmacy store colleagues will encourage clients to add $1 to their purchase at the register to aid the lifesaving research of St. Jude, among the world’s premier centers for the study and treatment of pediatric cancer tumor and additional catastrophic childhood diseases.